Strayer, D R <br/><br/>
A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Jan 1994 
 - S88-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1058-4838 
<br/><br/><label>Standard No.: </label>10.1093/clinids/18.supplement_1.s88  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Activities of Daily Living<br/>Adult<br/>Antiviral Agents--adverse effects<br/>Anxiety--complications<br/>Cognition--drug effects<br/>Depression--complications<br/>Double-Blind Method<br/>Drug Tolerance<br/>Exercise Test<br/>Fatigue Syndrome, Chronic--drug therapy<br/>Female<br/>Humans<br/>Karnofsky Performance Status<br/>Male<br/>Middle Aged<br/>Poly I-C--adverse effects<br/>Poly U--adverse effects<br/>RNA, Double-Stranded--adverse effects